MedPage Today on MSN
Trop2 Drug Extends Survival in EGFR-Mutated Lung Cancer
The Trop-2 protein is highly expressed in EGFR -mutated NSCLC, and resistance to EGFR TKIs such as osimertinib is associated ...
WFRV Green Bay on MSN
Appleton lung cancer survivor says stigma impacts research funding
Appleton lung cancer survivor says stigma impacts research funding Supreme Court Is Told Trump Tariffs Are Illegal $3 ...
A new multi-site study, published in JAMA, and co-led by researchers at the UNC Lineberger Comprehensive Cancer Center and ...
WFRV Green Bay on MSN
Appleton Man Beats Lung Cancer: Joe Toonen’s Journey & Advocacy
What Ole Miss football's Lane Kiffin said about his name coming up in Florida job search Man Watched Moose For Years—Then ...
The oral targeted therapy sevabertinib led to tumor reduction and manageable side effects in patients with HER2-mutant ...
Richard found what she was looking for. On Sept. 30, she became the first lung surgery patient at Northwestern Medicine to ...
A closely watched trial in Chinese patients is raising hope that ivonescimab will outperform Keytruda in a large global study ...
"Our study shows that reaching patients directly with digital tools can help overcome barriers to lung cancer screening and ...
More than two decades after the September 11 attacks, new research suggests that responders who worked amid the World Trade Center (WTC) dust and debris face nearly a 3-fold higher incidence of lung ...
Dr. J. Nicholas Bodor of Fox Chase Cancer Center explains possible risk factors, symptoms to watch for, and the importance of ...
A new targeted therapy is significantly improving lung cancer patient outcomes. The drug is called Osimertinib, or brand name ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results